News & Announcements

View: All Announcements Coverage

ImmuneBridge Raises $12M from M Ventures and Insight Partners to Advance Novel Natural Killer (NK) Cell-based Immunotherapies

Taylor Leigh 4/11/23 Taylor Leigh 4/11/23

ImmuneBridge Raises $12M from M Ventures and Insight Partners to Advance Novel Natural Killer (NK) Cell-based Immunotherapies

Biotech company taps into human diversity for next-generation NK cell therapies

Read More

For all media inquiries, please reach out to press@immunebridge.com.